Skip to content
Medium cut-off hemodialysis in multiple myeloma-associated cast nephropathy: A single-center experience
All contributors

Onconephrology contributor

Gratama, Jan W

Primarily Cellular therapy renal effects#42 of 47 recognized
  • #3 in Cellular therapy renal effects
4
Clinical papers
1,056
Citations (iCite)
0 / 3
First / senior author
2011–2016
Active years

Output over time

Clinical corpus papers per year — peak 2 in 2013.

  • 2011: 1 paper
  • 2013: 2 papers
  • 2016: 1 paper
20112016

Subfield mix

Clinical papers by onconephrology subfield (a paper can count in more than one).

Cellular therapy renal effects4

Frequent collaborators

Other recognized contributors who most often share corpus papers with Gratama (shared-paper count).

Lamers, Cor H J4

Verify

Representative recent papers, and this author’s full PubMed bibliography.

PMID 27284065 (opens PubMed in a new tab)PMID 23423337 (opens PubMed in a new tab)PMID 23388583 (opens PubMed in a new tab)PMID 20889925 (opens PubMed in a new tab)All papers on PubMed

A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.